LOC107986800: A Potential Drug Target for Cancer (G107986800)
LOC107986800: A Potential Drug Target for Cancer
LOC107986800, also known as LOC107986800 variant X3, is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is a key regulator of the cell cycle and is involved in the development and progression of various diseases, including cancer.
The LOC107986800 molecule was first identified in 2012 using RNA sequencing technology. It is a small non-coding RNA molecule that is expressed in most tissues and cells, but is highly expressed in the brain. It is also highly expressed in cancer tissues and cells, making it a potential biomarker for cancer.
One of the key functions of LOC107986800 is its role in the regulation of the cell cycle. The cell cycle is the process by which cells grow, divide, and replicate their genetic material. LOC107986800 is involved in the regulation of the G1 phase of the cell cycle, which is the phase when the cell prepares for cell division.
In addition to its role in the cell cycle, LOC107986800 is also involved in the regulation of apoptosis, which is the process by which cells die and are removed from the body. LOC107986800 has been shown to play a role in the regulation of apoptosis in various cell types, including cancer cells.
The potential drug target status of LOC107986800 is supported by several studies. For example, studies have shown that LOC107986800 can be targeted with small molecules, such as inhibitors, to inhibit its activity and prevent the progression of cancer cells. Additionally, LOC107986800 has been shown to interact with several protein molecules, including the transcription factor p53. This suggests that it may play a role in the regulation of gene expression and may be a potential target for drugs that target gene expression.
LOC107986800 has also been shown to be involved in the regulation of cell adhesion. Adhesion is the process by which cells stick together and form tissues. LOC107986800 is involved in the regulation of cell adhesion in various cell types, including cancer cells. This suggests that it may play a role in the development and progression of cancer.
In conclusion, LOC107986800 is a non-coding RNA molecule that is involved in the regulation of the cell cycle, apoptosis, and cell adhesion. Its potential drug target status is supported by several studies and suggests that it may be a useful biomarker or drug target for the treatment of various diseases, including cancer. Further research is needed to fully understand the role of LOC107986800 in the development and progression of disease.
Protein Name: Putative Uncharacterized Protein FLJ44672
More Common Targets
LOC107986816 | LOC107986820 | LOC107986836 | LOC107986844 | LOC107986873 | LOC107986892 | LOC107986894 | LOC107986901 | LOC107986903 | LOC107986927 | LOC107986930 | LOC107986952 | LOC107986961 | LOC107986983 | LOC107986996 | LOC107987026 | LOC107987045 | LOC107987049 | LOC107987053 | LOC107987057 | LOC107987064 | LOC107987087 | LOC107987099 | LOC107987121 | LOC107987164 | LOC107987178 | LOC107987211 | LOC107987243 | LOC107987249 | LOC107987251 | LOC107987282 | LOC107987285 | LOC107987299 | LOC107987301 | LOC107987304 | LOC107987407 | LOC107987412 | LOC107987429 | LOC107987435 | LOC107987440 | LOC107987443 | LOC107987449 | LOC107987453 | LOC107987459 | LOC112267867 | LOC112267881 | LOC112267902 | LOC112267956 | LOC112267962 | LOC112267968 | LOC112267978 | LOC112268051 | LOC112268136 | LOC112268248 | LOC112268286 | LOC112268294 | LOC112268416 | LOC114224 | LOC123862 | LOC124901339 | LOC126987 | LOC129026 | LOC132386 | LOC143666 | LOC145474 | LOC145845 | LOC148430 | LOC148696 | LOC149351 | LOC149684 | LOC151760 | LOC153893 | LOC153910 | LOC154449 | LOC154761 | LOC155060 | LOC157273 | LOC158434 | LOC158435 | LOC158696 | LOC162137 | LOC202181 | LOC221946 | LOC254896 | LOC260339 | LOC283028 | LOC283038 | LOC283045 | LOC283070 | LOC283194 | LOC283278 | LOC283299 | LOC283683 | LOC283731 | LOC283788 | LOC284009 | LOC284191 | LOC284240 | LOC284344 | LOC284379
